Virginia Commonwealth University
Maintaining Legitimacy While Managing Competition: Do Transplant Survival Ratings Affect Kidney Transplant Waitlisting?
Abstract
dc:description.abstractStatement of problem and objectives: Waitlisting is an essential step towards kidney transplantation among people with end-stage kidney disease (ESRD). There are no universal standards for waitlisting ESRD patients and how waitlists are managed in kidney transplant programs is opaque and under-studied. This study investigated whether the quality ratings of kidney transplant programs based on their one-year survival rates were associated with waitlist outcomes, including the number of waitlist additions, waitlist removals, the risk profiles of patients added or removed from a kidney transplant program’s waitlist, and whether market competition among kidney transplant programs attenuated these relationships. Procedure followed: This study employed a retrospective, observational design using secondary data from the USRDS, UNOS, and the SRTR to assess the relationships between one-year survival ratings, competition, and waitlist management activities using panel analysis methods. Competition was operationalized via the Herfindahl–Hirschman Index (HHI), and survival ratings were obtained from transplant program PSRs. Results: Lower one-year survival ratings were associated with fewer waitlist additions and more waitlist removals for non-medical reasons. Competition attenuated the relationship between one-year survival ratings and waitlist additions, but not the relationship between ratings and waitlist removals. No association was found between one-year survival ratings, competition, and clinical risk for either waitlist additions or removals. A sensitivity analysis employing multilevel logistic regression on waitlist removals further supported the findings by demonstrating that both patient-level factors and quality ratings independently affected the likelihood of removal, but only one interaction between patient-level clinical risk and quality ratings reached significance: history of drug use. Conclusions: The current quality rating framework may unintentionally restrict access to kidney transplantation. Moreover, waitlist “churn” may be an underrecognized consequence of the current quality rating framework.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Health Administration
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Placona, Andrew
- Contributors dc:contributor
-
- Shoou-Yih Daniel Lee
Subjects
dc:subject × 4Rights
dc:rights- Statement dc:rights
-
- © The Author
Identifiers
dc:identifier.*- Identifier
- https://scholarscompass.vcu.edu/etd/8401